Tags: Drug.

Retosiban (GSK-221149-A) is an oral drug which acts as a selective sub-nanomolar (Ki = 0.65 nM) oxytocin receptor antagonist with >1400-fold selectivity over the related vasopressin receptors and is being developed by GlaxoSmithKline for the treatment of preterm labour.

Retosiban_structure.svg
ATC prefix
None
CAS number
820957-38-8
FDA UNII code
GIE06H28OX
IUPAC name
(3R6R)-6-[(2S)-butan-2-yl]-3-(23-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-13-oxazol-4-yl)-2-(morpholin-4-yl)-2-oxoethyl]piperazine-25-dione
PubChem
96025669

Loading...

This page contains content from the copyrighted Wikipedia article "Retosiban"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.